No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1211 |
4. Check minimum number of eventsNone |
1211 |
5. Include endpointsNone |
1211 |
6. Filter based on genotype QC (FinnGen only) |
1076 |
Control definitions (FinnGen only)
- Control exclude
- G6_NEUINFL
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other encephalitis
based on the number of shared cases.
Similar with more cases:
- Encephalitis
- Inflammatory diseases of the central nervous system
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 8321 | 4179 | 4069 |
| Only index persons | 7092 | 3622 | 3470 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.12 | 0.12 | 0.11 |
| Only index persons | 0.13 | 0.13 | 0.13 |
| Median age at first event (years) | |||
| Whole population | 44.69 | 46.74 | 42.37 |
| Only index persons | 42.17 | 44.29 | 39.97 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1076 | 601 | 475 |
| Unadjusted period prevalence (%) | 0.22 | 0.21 | 0.22 |
| Median age at first event (years) | 51.21 | 47.94 | 55.35 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1118
- Matched controls
- 11180
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
+∞
307.7
536
*
TAB00
NOMESCO Finland
Lumbar puncture
17.4
307.7
298
229
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
8.5
207.2
320
501
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
13.3
163.8
165
144
N03AX14
ATC
levetiracetam; systemic
13.3
142.7
142
121
G05.1*B00.4
ICD-10 Finland
Herpesviral meningoencephalitis
+∞
140.7
132
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
8.3
129.5
187
264
XA800
NOMESCO Finland
Neuropsychological investigation
9.1
128.4
170
216
G04.8
ICD-10 Finland
Other encephalitis, myelitis and encephalomyelitis
+∞
125.4
118
*
A86
ICD-10 Finland
Unspecified viral encephalitis
197.1
120.1
123
7
G40.9
ICD-10 Finland
Epilepsy, unspecified
10.0
116.9
142
161
AA1AD
NOMESCO Finland
CT of head and brain
4.0
111.5
526
2044
32309
ICD-8 Finland
Encephalitis, myelitis and encephalomyelitis, Unspecified
+∞
110.3
104
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
12.0
100.2
105
96
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
12.2
86.4
89
79
N03AX18
ATC
lacosamide; systemic
24.5
78.3
56
24
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
14.6
76.4
70
51
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.5
73.4
323
1150
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.8
71.7
141
270
A87.9
ICD-10 Finland
Viral meningitis, unspecified
24.2
71.0
51
22
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.2
70.8
219
611
G35
ICD-10 Finland
Multiple sclerosis
12.8
70.8
70
58
N03AF02
ATC
oxcarbazepine; oral
7.2
64.6
101
153
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
11.6
61.1
64
58
R4150
NOMESCO Finland
Neuropsychological rehabilitation
16.3
58.3
50
32
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.2
57.2
287
1090
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
9.1
55.2
69
80
R4120
NOMESCO Finland
Occupational therapy
4.4
54.8
151
383
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
19.8
53.8
42
22
G05.1*J09
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis in influenza caused by certain identified influenza viruses
+∞
53.6
51
*
ZX120
NOMESCO Finland
Intravenous
3.9
53.2
180
530
5AB01, ,
NOMESCO Finland
115.6
51.3
55
5
G05.8*M32.1
ICD-10 Finland
Encephalitis in systemic lupus erythematosus
+∞
48.3
46
*
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
15.5
47.9
42
28
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
15.0
47.0
42
29
G05.1*B01.1
ICD-10 Finland
Varicella encephalitis
+∞
45.1
43
*
N05BA09
ATC
clobazam; oral
16.6
43.7
37
23
G05.1
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere
+∞
43.0
41
*
R41.0
ICD-10 Finland
Disorientation, unspecified
6.3
42.0
73
123
N03AG01
ATC
valproic acid; systemic, rectal
4.0
40.9
126
345
G05.1*B02.0
ICD-10 Finland
Zoster encephalitis
+∞
40.9
39
*
B00.4
ICD-10 Finland
Herpesviral encephalitis
411.8
40.4
40
*
A28
ICPC
Limited function/disability NOS
2.7
39.8
260
1119
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
39.6
607
3826
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.5
39.6
152
483
F05.9
ICD-10 Finland
Delirium, unspecified
7.5
37.6
55
77
N99
ICPC
Neurological disease other
9.5
36.7
44
48
G03.9
ICD-10 Finland
Meningitis, unspecified
368.7
36.2
36
*
R50.9
ICD-10 Finland
Fever, unspecified
2.6
36.0
245
1072
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
35.9
311
1525
109
Kela drug reimbursment
Multiple sclerosis
10.1
34.9
40
41
XF400
NOMESCO Finland
ECG with 12 standard connections
2.7
34.1
224
961
183
Kela drug reimbursment
Lamotrigin and topiramate
10.6
33.5
37
36
R4130
NOMESCO Finland
Speech therapy
5.5
32.8
65
124
Z2445
NOMESCO Finland
Psychologist
4.2
32.2
89
224
3238B
ICD-9 Finland
Encephalitis, myelitis and encephalomyelitis, Other causes of encephalitis[ENCEPHALITIS (MYELITIS,ENCEPHALOMYELITIS) VIROSA]
+∞
31.4
30
*
R4110
NOMESCO Finland
Physiotherapy
2.2
30.9
368
2044
WX892
NOMESCO Finland
Monitored bed care
3.3
30.9
129
430
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.5
29.4
222
1013
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
6.4
29.3
49
79
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.5
29.2
108
333
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
106.2
28.8
31
*
L04AA06
ATC
mycophenolic acid; systemic
5.9
28.7
52
91
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
10.0
28.7
33
34
N03AB02
ATC
phenytoin; systemic
8.2
28.3
38
48
N03AX12
ATC
[U] gabapentin; oral
2.4
28.2
224
1044
L28
ICPC
Limited function/disability (L)
2.3
27.4
250
1238
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
6.0
27.3
49
85
R20.2
ICD-10 Finland
Paraesthesia of skin
3.1
27.0
122
425
2AB04, ,
NOMESCO Finland
99.2
26.8
29
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.6
26.1
165
689
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
9.1
26.0
32
36
N03AX16
ATC
[U] pregabalin
2.2
25.9
292
1571
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.7
25.7
154
625
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
9.3
25.7
31
34
H02AB09
ATC
hydrocortisone; systemic
5.2
25.6
53
105
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
25.2
333
1900
B94.1
ICD-10 Finland
Sequelae of viral encephalitis
+∞
25.1
24
*
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.6
24.6
60
137
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.4
24.1
185
845
N71
ICPC
Meningitis/encephalitis
+∞
24.0
23
*
R51.80
ICD-10 Finland
Headache
2.2
23.8
231
1166
6BA02, ,
NOMESCO Finland
42.4
23.7
29
7
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.7
23.5
138
554
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
9.0
23.4
29
33
Z3226
NOMESCO Finland
Physiotherapist
2.2
23.0
237
1224
G05.1*J10.8
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis in influenza caused by other identified influenza virus
+∞
23.0
22
*
TKC20
NOMESCO Finland
Catheterisation of bladder
3.1
22.8
103
358
L04AX01
ATC
azathioprine; systemic
3.6
22.4
77
226
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
8.5
22.3
29
35
R33
ICD-10 Finland
Retention of urine
2.9
22.3
112
414
G41.9
ICD-10 Finland
Status epilepticus, unspecified
22.7
21.8
31
14
M05BA04
ATC
alendronic acid; oral
2.8
21.6
114
432
H02AB07
ATC
prednisone; oral
2.3
21.4
178
840
H02AB06
ATC
prednisolone; systemic
1.8
20.9
548
3867
Z3231
NOMESCO Finland
Registered nurse
1.9
20.7
332
2006
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
5.4
20.2
40
76
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
49.0
20.2
24
5
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
19.8
179
874
R42
ICD-10 Finland
Dizziness and giddiness
2.0
19.7
279
1612
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
19.4
379
2431
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.8
19.4
106
409
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.5
19.3
136
595
N28
ICPC
Limited function/disability (N)
5.7
19.2
36
65
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
4.4
19.2
49
116
Z2221
NOMESCO Finland
Medical doctor
1.9
19.1
328
2019
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.0
18.9
90
322
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.0
18.8
88
312
XA400
NOMESCO Finland
EEG
17.5
18.8
29
17
N03AF01
ATC
carbamazepine; oral, rectal
3.1
18.1
78
264
J05AB11
ATC
valaciclovir; oral
2.1
18.0
189
976
M03BX01
ATC
baclofen; systemic
4.8
17.9
40
85
WW400
NOMESCO Finland
Plasmaferesis
67.7
17.8
20
*
G05.1*A85.0
ICD-10 Finland
Encephalitis, myelitis or encephalomyelitis (in) enteroviral
+∞
17.8
17
*
32308
ICD-8 Finland
Encephalitis, myelitis and encephalomyelitis, Alia definita
+∞
17.8
17
*
WX730
NOMESCO Finland
Conventional respirator
6.3
17.7
30
49
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
6.9
17.5
27
40
C03CA01
ATC
furosemide; systemic
1.8
17.0
321
2022
RS221, ,
NOMESCO Finland
5.8
16.9
31
55
G02.0*B00.3
ICD-10 Finland
Herpesviral meningitis
+∞
16.7
16
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.8
16.5
86
323
G37.3
ICD-10 Finland
Acute transverse myelitis in demyelinating disease of central nervous system
172.5
16.5
17
*
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
6.2
16.4
28
46
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
6.4
16.3
27
43
N03AX09
ATC
lamotrigine; oral
3.0
16.2
75
264
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.7
16.1
30
54
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
7.0
15.7
24
35
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
13.1
15.7
27
21
G09
ICD-10 Finland
Sequelae of inflammatory diseases of central nervous system
+∞
15.7
15
*
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
17.5
15.6
24
14
ZXD05
NOMESCO Finland
Urgent procedure
1.7
15.4
346
2283
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
15.4
391
2670
N05BA01
ATC
diazepam; systemic, rectal
2.1
15.4
162
836
J01MA12
ATC
levofloxacin; systemic
1.9
15.2
212
1208
N03AE01
ATC
clonazepam; systemic
2.8
15.1
76
281
G04.0
ICD-10 Finland
Acute disseminated encephalitis
+∞
14.6
14
*
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.6
14.6
48
137
G40.89
ICD-10 Finland
Other epilepsy
15.6
14.4
23
15
JN4BD
NOMESCO Finland
Extensive body CT
2.3
14.4
122
577
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.6
14.3
84
336
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.7
14.3
33
72
ZXD35
NOMESCO Finland
Usual procedure
3.4
14.0
50
151
J01AA02
ATC
doxycycline; systemic
1.7
14.0
830
6991
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
54.0
13.8
16
*
G41.0
ICD-10 Finland
Grand mal status epilepticus
54.0
13.8
16
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.4
13.8
99
436
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.7
13.7
73
278
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.2
13.6
36
88
J05AB01
ATC
aciclovir; systemic
1.8
13.5
249
1545
73410
ICD-8 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
141.7
13.5
14
*
J01DB01
ATC
cefalexin; oral
1.8
13.3
914
7947
Z2446
NOMESCO Finland
Social worker
2.4
13.3
94
410
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
40.6
13.2
16
*
N06AX11
ATC
mirtazapine; oral
1.6
13.1
384
2697
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
3.9
13.1
38
99
P01BA02
ATC
hydroxychloroquine; oral
2.4
13.1
98
439
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
4.8
12.9
29
62
R11
ICD-10 Finland
Nausea and vomiting
2.2
12.9
118
576
H53.2
ICD-10 Finland
Diplopia
3.2
12.8
51
165
A06AD11
ATC
lactulose; oral
2.0
12.7
162
892
J01MA02
ATC
ciprofloxacin; systemic
1.6
12.6
413
2977
N05CF01
ATC
zopiclone; oral
1.7
12.5
341
2347
G01*A69.2
ICD-10 Finland
Meningitis (in) Lyme disease
+∞
12.5
12
*
F07.1
ICD-10 Finland
Postencephalitic syndrome
+∞
12.5
12
*
ZXY02
NOMESCO Finland
Neuropsychologist
10.2
12.5
24
24
R47.0
ICD-10 Finland
Dysphasia and aphasia
9.4
12.5
25
27
N03AX23
ATC
brivaracetam; systemic
20.3
12.5
18
9
N05AH04
ATC
quetiapine; oral
1.8
12.4
217
1322
A02BC02
ATC
pantoprazole; systemic
1.6
12.3
730
6034
R53
ICD-10 Finland
Malaise and fatigue
1.7
12.2
299
2001
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
12.2
133
694
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
3.0
12.1
53
181
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
21.6
12.0
17
8
N03AX11
ATC
topiramate; oral
3.5
12.0
42
125
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
12.0
208
1263
G95.9
ICD-10 Finland
Disease of spinal cord, unspecified
30.4
11.7
15
5
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
11.7
120
612
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.0
11.5
50
170
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.6
11.5
69
279
G73.7*M32.1
ICD-10 Finland
Myopathy in systemic lupus erythematosus
+∞
11.5
11
*
G40
ICD-10 Finland
Epilepsy
5.5
11.4
22
41
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.8
11.2
179
1059
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
5.6
11.2
21
38
PA6AD
NOMESCO Finland
CT of neck arteries
2.8
11.1
54
196
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.5
11.0
70
291
B02.0
ICD-10 Finland
Zoster encephalitis
43.8
10.9
13
*
G81.9
ICD-10 Finland
Hemiplegia, unspecified
5.5
10.9
21
39
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.9
10.9
136
743
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.3
10.9
84
382
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
10.8
271
1816
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.9
10.8
153
871
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
10.8
223
1421
J96.0
ICD-10 Finland
Acute respiratory failure
4.8
10.7
24
51
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.8
10.5
53
196
N29
ICPC
Neurological sympt/complt other
4.1
10.5
29
73
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
10.2
10.5
20
20
R1260
NOMESCO Finland
Evaluation of communicative skills
4.1
10.5
28
69
G05.1*J11.8
ICD-10 Finland
Encephalitis, myelitis or encephalomyelitis in suspected influenza
+∞
10.4
10
*
M31.1
ICD-10 Finland
Thrombotic microangiopathy
+∞
10.4
10
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.2
10.4
40
127
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
32.8
10.3
13
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
10.2
297
2062
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.1
10.2
101
508
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
5.3
10.1
20
38
L04AA01
ATC
[U] ciclosporin
5.3
10.1
20
38
N88
ICPC
Epilepsy
8.5
10.1
21
25
JN4AD
NOMESCO Finland
Body CT examination
1.9
10.0
126
691
WX704
NOMESCO Finland
Intubation
2.1
9.9
95
471
A41.9
ICD-10 Finland
Sepsis, unspecified
2.9
9.9
47
169
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.4
9.8
24
55
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
9.8
243
1620
B01AB05
ATC
enoxaparin; parenteral
1.6
9.5
316
2256
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.3
9.5
35
108
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.0
9.4
98
501
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.9
9.4
123
681
N02AA05
ATC
oxycodone; systemic
1.7
9.4
184
1152
AAA10
NOMESCO Finland
Biopsy through craniotomy
+∞
9.4
9
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
9.4
119
653
SPAT1254
SPAT
Administration of medicine
1.8
9.4
165
1003
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
4.7
9.3
21
45
N18
ICPC
Paralysis/weakness
3.7
9.3
29
80
SPAT1216
SPAT
Assessment of functional ability
1.8
9.3
158
951
WX882
NOMESCO Finland
High dependency care
3.0
9.2
39
131
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.3
9.2
73
336
N05BA04
ATC
oxazepam; oral
1.6
9.2
279
1950
SPAT1255
SPAT
Intravenous administration of medicine
2.2
9.2
76
356
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.6
9.2
53
211
G61.0
ICD-10 Finland
Guillain-Barré syndrome
11.6
9.1
16
14
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.2
9.1
79
378
L01BA01
ATC
methotrexate; systemic
2.9
8.8
42
151
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.0
8.7
98
516
N03AX25
ATC
cenobamate; oral
50.4
8.7
10
*
R51
ICD-10 Finland
Headache
2.2
8.7
71
331
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.3
8.7
32
99
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
4.8
8.6
19
40
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
4.8
8.6
19
40
UKC02
NOMESCO Finland
Cystoscopy
1.7
8.6
157
963
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
9.1
8.5
17
19
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.9
8.5
108
592
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
8.5
223
1503
ADB00
NOMESCO Finland
Implantation of vagus nerve stimulating device
27.7
8.5
11
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.1
8.5
80
395
ZXA00
NOMESCO Finland
Right side
1.6
8.4
258
1802
3069, ,
Kela drug reimbursment
90.7
8.4
9
*
A84.8
ICD-10 Finland
Other tick-borne viral encephalitis
90.7
8.4
9
*
1541, ,
Kela drug reimbursment
90.7
8.4
9
*
L89
ICD-10 Finland
Decubitus ulcer and pressure area
3.5
8.4
28
81
M35.1
ICD-10 Finland
Other overlap syndromes
12.9
8.4
14
11
F05.8
ICD-10 Finland
Other delirium
7.9
8.4
18
23
Z3229
NOMESCO Finland
Other healthcare associate professional
2.0
8.3
88
453
L04AX07
ATC
dimethyl fumarate; oral
9.5
8.3
16
17
WX872
NOMESCO Finland
Intensive care
2.3
8.2
59
260
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
8.2
561
4598
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
6.5
8.2
20
31
N02AX02
ATC
tramadol; systemic, rectal
1.5
8.2
432
3373
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.9
8.2
115
652
R5110, ,
SPAT
2.0
8.2
93
492
A69.2
ICD-10 Finland
Lyme disease
2.1
8.2
73
353
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
8.1
141
852
N06AA09
ATC
amitriptyline; systemic
2.0
8.1
94
500
N05CD08
ATC
midazolam; nasal, systemic
3.1
8.1
33
109
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.1
8.0
73
355
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.7
8.0
43
165
H53.4
ICD-10 Finland
Visual field defects
3.3
8.0
29
89
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
3.8
7.9
24
65
L03AB07
ATC
interferon beta-1a; parenteral
7.8
7.9
17
22
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
4.1
7.8
21
52
A02BC01
ATC
omeprazole; systemic
1.5
7.8
270
1935
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.2
7.8
66
313
A04
ICPC
Weakness/tiredness general
1.6
7.7
171
1104
J01FF01
ATC
clindamycin; systemic
1.5
7.7
273
1967
SPAT1167
SPAT
Insertion of urinary catheter
2.9
7.6
36
129
H02AB04
ATC
methylprednisolone; systemic
1.7
7.6
152
955
G41.2
ICD-10 Finland
Complex partial status epilepticus
25.2
7.6
10
*
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.5
7.6
45
182
N02BF01
ATC
gabapentin; oral
1.8
7.6
110
631
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.0
7.5
32
108
R41.3
ICD-10 Finland
Other amnesia
2.9
7.5
34
119
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.4
7.5
52
226
N02BF02
ATC
pregabalin; oral
2.0
7.5
75
379
N86
ICPC
Multiple sclerosis
7.7
7.4
16
21
G36.9
ICD-10 Finland
Acute disseminated demyelination, unspecified
13.5
7.4
12
9
N05AH03
ATC
olanzapine; systemic
2.0
7.4
76
388
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
7.4
116
681
NF1AA
NOMESCO Finland
Hip X-ray examination
1.9
7.3
90
489
WW200
NOMESCO Finland
Immunization
2.9
7.3
34
121
32099
ICD-8 Finland
Meningitis, With no organism specified as cause
+∞
7.3
7
*
Z71.8
ICD-10 Finland
Other specified counselling
1.4
7.3
360
2765
WX002
NOMESCO Finland
Sedation and analgesia
1.6
7.2
189
1269
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
15.9
7.2
11
7
T78.4
ICD-10 Finland
Allergy, unspecified
2.3
7.2
52
230
R60.0
ICD-10 Finland
Localized oedema
1.7
7.2
127
772
R06AE07
ATC
cetirizine; oral
1.4
7.1
450
3606
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.1
7.1
67
331
G40.10
ICD-10 Finland
Simple partial seizures
8.0
7.1
15
19
XW000
NOMESCO Finland
Bone marrow biopsy
2.5
7.1
45
188
XCK00
NOMESCO Finland
Perimetry
2.2
7.1
61
291
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
5.7
7.1
19
34
XF600
NOMESCO Finland
Bloodpressure measurement
2.1
7.1
67
332
U07
ICPC
Urine symptom/complaint other
1.9
7.0
88
481
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
4.2
7.0
18
43
N06AX21
ATC
duloxetine; oral
1.7
7.0
127
777
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
7.0
264
1921
N02BE01
ATC
paracetamol; systemic, rectal
1.6
7.0
953
8765
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.9
6.9
31
108
H46
ICD-10 Finland
Optic neuritis
5.5
6.9
19
35
N30.0
ICD-10 Finland
Acute cystitis
1.6
6.9
176
1174
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.9
6.9
93
521
TKC22
NOMESCO Finland
Catheterisation instruction
3.2
6.9
27
87
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.0
6.9
71
363
OAB93, ,
SPAT
1.9
6.9
80
427
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.2
6.9
53
242
B02.8
ICD-10 Finland
Zoster with other complications
6.7
6.8
16
24
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.1
6.8
60
289
N06BA07
ATC
modafinil; oral
9.4
6.8
13
14
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.2
6.8
56
263
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
4.3
6.8
17
40
G36.0
ICD-10 Finland
Neuromyelitis optica [Devic]
40.3
6.8
8
*
N05CD07
ATC
temazepam; oral
1.8
6.7
110
653
SPAT1234
SPAT
Support of social functional capacity
2.2
6.7
55
257
A46
ICD-10 Finland
Erysipelas
1.6
6.7
144
921
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.1
6.7
62
305
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.5
6.7
41
169
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.4
6.7
46
200
XKD00
NOMESCO Finland
Uroflowmetry
1.7
6.7
137
867
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
6.6
367
2866
K59.09
ICD-10 Finland
Constipation, unspecified
2.0
6.6
71
368
5CM18, ,
NOMESCO Finland
7.9
6.6
14
18
XKC03
NOMESCO Finland
Water cystometry
2.7
6.6
34
128
H53.1
ICD-10 Finland
Subjective visual disturbances
1.9
6.6
77
411
L04AX03
ATC
methotrexate; systemic
1.8
6.6
100
581
G93.4
ICD-10 Finland
Encephalopathy, unspecified
12.3
6.6
11
9
G83.4
ICD-10 Finland
Cauda equina syndrome
10.1
6.5
12
12
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
10.1
6.5
12
12
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
6.5
763
6748
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
6.5
313
2383
L04AD01
ATC
ciclosporin; systemic
3.1
6.5
26
85
S97
ICPC
Chronic ulcer skin
2.0
6.5
68
350
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.3
6.5
46
203
NA7CM
NOMESCO Finland
Spine and spinal cord extensive MRI examination with 3 Tesla magnet
70.2
6.4
7
*
A89
ICD-10 Finland
Unspecified viral infection of central nervous system
70.2
6.4
7
*
G00.9
ICD-10 Finland
Bacterial meningitis, unspecified
70.2
6.4
7
*
WVA20
NOMESCO Finland
Medicine administration
2.6
6.4
36
142
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
14.4
6.4
10
7
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
6.3
375
2958
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.4
6.3
40
167
N06AX16
ATC
venlafaxine; oral
1.6
6.3
151
992
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.1
6.3
61
305
M32
ICD-10 Finland
Systemic lupus erythematosus
18.1
6.3
9
5
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
18.1
6.3
9
5
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.4
6.3
40
168
3238X
ICD-9 Finland
Encephalitis, myelitis and encephalomyelitis, Other causes of encephalitis[ENCEPHALITIS (MYELITIS, ENCEPHALOMYELITIS) ALIA DEF]
+∞
6.3
6
*
B01.1
ICD-10 Finland
Varicella encephalitis
+∞
6.3
6
*
GBB03
NOMESCO Finland
Percutaneous tracheostomy
+∞
6.3
6
*
G06.0
ICD-10 Finland
Intracranial abscess and granuloma
+∞
6.3
6
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.8
6.2
98
576
ZXA05
NOMESCO Finland
Left side
1.5
6.2
226
1630
L88
ICPC
Rheumatoid/seropositive arthritis
2.3
6.1
43
189
K93
ICPC
Pulmonary embolism
4.1
6.1
16
39
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
6.1
197
1385
N03AX22
ATC
perampanel; oral
12.6
6.1
10
8
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.5
6.1
38
158
ZXE00
NOMESCO Finland
One hour or less
1.4
6.1
382
3040
B34.9
ICD-10 Finland
Viral infection, unspecified
2.5
6.1
37
152
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.8
6.1
97
573
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
3.6
6.1
19
53
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.9
6.0
72
388
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.6
6.0
144
946
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.3
6.0
42
184
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.8
6.0
89
514
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.9
6.0
77
425
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
183
39
55.91
319.25
1.5
2.3
—
—
—
0
0
254
88
37.06
307.65
1.2
1.1
—
—
—
0
0
201
37
66.01
307.65
1.3
1.1
—
—
—
0
0
277
88
41.52
307.65
1.4
1.7
—
—
—
0
0
280
54
68.84
307.65
1.3
1.0
—
—
—
0
0
426
247
27.25
307.65
1.7
1.3
694.79
457.99
mg/l
10.64
420
234
424
220
30.44
307.65
1.6
1.2
3.61
3.76
mmol/l
1.08
409
209
364
221
23.94
307.65
1.8
1.5
690.73
675.74
e6/l
0.01
268
169
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
239
51
59.33
307.65
1.3
1.1
—
—
—
0
0
362
218
24.08
307.65
1.7
1.4
84.36
8.54
e6/l
1.49
257
159
172
73
27.66
245.30
1.5
1.1
57.86
39.99
mg/l
1.93
156
57
125
15
93.70
238.79
1.2
1.1
—
—
—
0
0
166
69
28.08
238.43
1.3
1.1
341.26
232.83
mg/l
3.98
156
60
139
35
45.21
232.15
1.2
1.1
226.57
17.50
ng/l
—
67
6
138
34
46.16
231.69
1.2
1.1
—
—
—
0
0
160
68
27.29
227.73
1.3
1.0
—
—
—
0
0
126
23
61.61
225.34
1.3
1.0
—
—
—
0
0
123
24
57.46
217.07
1.3
1.0
—
—
—
0
0
122
23
59.42
216.74
1.3
1.0
—
—
—
0
0
117
21
62.11
209.68
1.2
1.1
—
—
—
0
0
358
666
7.44
197.26
2.8
2.4
25.46
18.74
au/ml
0.51
25
68
185
147
14.88
195.27
1.3
1.1
—
—
—
0
0
139
62
25.46
193.66
1.4
1.2
0.62
0.52
ratio
2.30
86
36
337
603
7.57
192.31
1.5
1.3
74.58
41.99
au/ml
1.26
19
47
109
24
50.21
187.19
1.3
1.0
—
—
—
0
0
124
61
22.74
165.65
1.4
1.0
1.16
1.08
u/l
0.44
55
32
71
11
68.85
129.70
1.5
1.0
—
—
—
0
0
192
285
7.93
127.24
1.2
1.1
1.38
3.99
—
5
40
119
99
13.33
120.96
1.5
1.9
—
—
—
0
0
316
813
5.02
117.57
3.8
2.6
9.90
10.69
g/l
2.38
296
753
67
15
47.45
113.92
1.4
1.3
—
—
—
0
0
83
38
23.51
113.57
1.1
1.0
—
—
—
0
0
54
10
56.69
95.24
1.4
1.1
—
—
—
0
0
53
13
42.75
87.94
1.2
1.0
—
—
—
0
0
52
13
41.90
85.86
1.2
1.0
—
—
—
0
0
50
14
37.34
80.12
1.2
1.0
—
—
—
0
0
73
56
13.88
77.39
3.2
2.3
232.05
195.96
e6/l
0.62
64
47
86
88
10.50
75.74
1.6
1.9
—
—
—
0
0
45
11
42.58
74.57
1.6
1.4
—
—
—
0
0
70
56
13.27
72.34
3.1
2.1
516.12
492.07
e6/l
0.10
60
43
392
1595
3.24
71.48
2.2
1.9
—
—
—
0
0
573
2927
2.96
69.22
3.2
2.2
221.65
245.01
u/l
0.17
559
2788
364
1472
3.18
66.35
2.7
2.3
28.79
29.45
s
1.93
359
1429
320
1202
3.33
65.98
2.1
1.8
—
—
—
0
0
66
56
12.46
65.73
1.4
1.0
1594.97
1605.80
miu/ml
0.02
66
56
64
5
135.62
60.52
1.3
1.2
—
—
—
0
0
66
8
87.67
59.64
1.4
1.1
—
—
—
0
0
63
59
11.26
58.80
2.9
2.1
—
—
—
0
0
49
30
17.04
58.46
1.4
1.2
14.95
17.00
%
—
21
5
117
227
5.64
58.39
3.0
3.6
28.10
33.81
umol/l
2.25
102
209
296
1142
3.17
57.48
2.2
1.9
—
—
—
0
0
690
4175
2.70
55.92
6.4
5.3
34.77
35.98
g/l
5.66
661
3932
136
322
4.67
53.79
1.3
1.3
—
—
—
0
0
675
4200
2.53
49.05
10.3
7.2
1.20
1.21
mmol/l
3.41
634
3894
58
63
9.66
48.69
1.2
1.2
—
—
—
0
0
128
313
4.49
48.48
5.2
1.6
0.21
0.23
g/l
2.44
122
302
129
325
4.36
46.98
5.3
1.6
1.10
1.19
g/l
2.97
123
312
51
7
76.06
45.36
1.3
1.1
—
—
—
0
0
811
5614
2.62
45.15
8.4
5.5
6.74
6.64
mmol/l
0.55
789
5304
456
2440
2.47
45.10
5.5
4.3
89.82
90.86
%
0.42
444
2390
721
4732
2.47
44.99
10.9
7.8
1.21
1.21
mmol/l
1.08
637
4112
478
2695
2.35
41.12
4.8
3.3
0.28
0.40
e6/l
1.39
367
1962
184
645
3.22
40.97
2.5
1.7
1.18
1.40
g/l
0.87
169
602
530
3129
2.32
40.85
4.9
3.4
39.61
74.39
e6/l
0.74
420
2371
47
8
61.23
40.56
1.3
1.1
—
—
—
0
0
797
5635
2.44
39.63
14.6
9.9
4.27
4.08
e9/l
1.35
696
4914
144
448
3.54
38.72
1.9
2.1
33.22
38.73
u/l
3.05
133
405
197
748
2.98
38.05
2.3
3.0
65.63
66.71
g/l
0.87
182
700
163
572
3.17
36.01
1.9
1.7
—
—
—
0
0
138
439
3.45
35.76
5.9
1.9
15.97
6.75
iu/ml
1.69
45
103
328
1658
2.38
35.27
4.3
3.0
1.09
1.02
e6/l
0.14
173
861
94
231
4.35
35.16
1.5
1.6
—
—
—
0
0
277
1302
2.50
34.94
8.0
6.5
1.04
1.05
mmol/l
0.39
259
1208
639
4263
2.16
34.34
15.3
13.8
1.22
1.23
inr
0.27
541
3552
838
6253
2.36
33.74
7.1
4.6
354.25
1306.85
e6/l
—
8
97
68
134
5.34
33.11
1.6
2.0
—
2640.00
—
0
5
316
1616
2.33
32.74
4.5
3.9
0.81
0.82
mmol/l
0.21
291
1542
112
330
3.66
32.54
2.3
2.8
—
—
—
0
0
36
6
61.91
31.23
1.1
1.0
—
—
—
0
0
35
5
72.04
31.04
1.1
1.0
—
—
—
0
0
231
1052
2.51
30.81
4.5
4.8
274.18
254.21
u/l
0.31
218
996
78
184
4.48
30.70
1.4
1.3
—
—
—
0
0
78
184
4.48
30.70
1.4
1.3
—
—
—
0
0
113
349
3.49
30.54
1.7
1.5
0.15
0.09
iu/ml
0.18
22
59
301
1554
2.28
30.17
4.4
3.2
3.10
2.43
e6/l
0.35
142
754
378
2149
2.15
29.74
3.5
2.7
4.42
6.14
e6/l
2.59
353
1966
215
981
2.48
28.38
4.8
4.3
1.45
1.83
mmol/l
0.82
189
838
210
964
2.45
27.28
2.6
2.1
351.20
377.33
nmol/l
1.23
197
904
100
309
3.46
26.95
1.9
2.8
10.62
10.35
g/l
0.15
85
284
57
120
4.95
25.72
1.1
1.2
—
—
—
0
0
64
150
4.47
25.37
5.5
6.3
331.14
371.65
umol/l
1.61
57
134
691
5063
1.96
25.17
7.7
6.7
10.33
11.87
umol/l
4.13
667
4845
72
186
4.07
25.14
3.0
3.7
1951.60
2076.21
u/ml
—
5
14
589
4101
1.92
24.93
2.5
2.1
92.94
95.77
pmol/l
0.81
337
2177
106
359
3.16
24.60
1.9
2.6
3.70
3.70
g/l
0.00
91
335
106
359
3.16
24.60
1.9
2.6
7.29
7.35
g/l
0.11
90
335
106
359
3.16
24.60
1.9
2.6
3.97
4.24
g/l
1.95
91
335
90
278
3.43
24.23
2.0
2.3
11.72
11.54
mg/l
0.07
81
261
898
7296
2.17
23.48
11.8
8.3
78.29
79.07
u/l
0.24
872
6959
184
850
2.39
23.33
7.9
8.6
8.48
9.41
mmol/l
1.05
176
820
186
866
2.38
23.16
4.0
3.8
4.76
4.53
kpa
0.82
181
845
275
1504
2.10
23.06
1.8
1.7
992.81
1169.10
nmol/l
3.05
219
1142
39
64
6.28
22.94
3.7
2.6
43.49
41.23
%
0.24
23
31
100
341
3.12
22.91
2.0
2.7
2.93
2.95
g/l
0.06
85
317
192
912
2.33
22.82
10.8
9.0
1.50
1.34
mmol/l
1.20
185
895
31
12
26.52
22.73
1.2
1.1
—
—
—
0
0
32
14
23.49
22.67
1.5
1.6
—
—
—
0
0
80
239
3.53
22.67
5.1
6.9
266.13
317.77
iu/ml
—
8
30
314
1814
2.02
22.62
4.0
3.9
103.78
416.93
ng/l
4.42
240
1348
97
329
3.13
22.42
2.1
1.8
—
—
—
0
0
71
198
3.76
22.27
1.3
1.5
—
—
—
0
0
81
248
3.44
22.10
1.9
3.0
0.00
0.00
g/l
-0.00
71
235
86
275
3.30
21.90
1.8
2.9
0.04
0.02
g/l
0.22
73
251
85
270
3.32
21.88
1.6
1.7
—
—
—
0
0
213
1078
2.21
21.67
11.7
9.5
1.14
0.87
mmol/l
0.39
176
893
608
4407
1.83
21.42
15.1
11.3
0.00
0.00
e9/l
0.59
479
3599
84
269
3.30
21.34
1.8
2.9
0.00
0.00
g/l
-0.00
71
236
214
1098
2.17
20.99
11.7
9.4
4.99
5.11
kpa
1.04
204
1061
214
1099
2.17
20.94
11.6
9.4
11.82
12.28
kpa
0.71
204
1064
91
314
3.07
20.41
1.8
2.9
1.39
0.79
g/l
0.43
75
279
62
169
3.83
20.09
1.5
1.2
3.21
6.61
u/ml
0.96
39
70
25
7
36.48
19.89
1.3
1.0
—
—
—
0
0
858
7057
1.93
18.79
6.7
4.4
13.28
11.35
mm/h
3.39
824
6632
78
262
3.13
18.31
1.5
1.7
—
—
—
0
0
665
5111
1.74
17.72
5.9
3.8
0.00
0.00
estimate
0.50
135
1077
669
5166
1.73
17.37
5.9
3.8
7.80
4.47
estimate
0.16
138
1098
673
5207
1.73
17.34
5.9
3.9
0.00
0.31
estimate
0.53
127
1026
96
373
2.72
17.32
2.3
2.1
1.10
2.10
ug/l
0.64
89
332
350
2266
1.79
16.95
2.0
1.8
1.00
1.20
mg/l
0.78
272
1727
337
2164
1.80
16.74
2.1
1.5
2.13
2.39
g/l
2.41
236
1362
16
0
+∞
16.70
1.1
0.0
—
—
—
0
0
581
4367
1.69
16.20
3.0
2.6
75.31
75.89
nmol/l
0.18
538
3979
385
2591
1.74
16.15
2.6
2.3
2.96
2.81
mg/l
0.45
332
2226
472
3361
1.70
16.10
4.6
3.4
40.99
32.06
u/l
0.57
446
3196
184
981
2.05
16.02
12.7
9.9
95.46
95.63
%
0.10
179
951
100
418
2.53
15.56
2.6
2.3
1.68
1.45
g/l
1.39
83
373
459
3285
1.67
15.09
3.8
3.5
2.34
2.35
mmol/l
1.35
420
3014
81
310
2.74
15.04
1.7
1.2
32.94
3.14
u/ml
—
7
12
55
169
3.37
14.93
1.5
1.2
4.12
4.98
u/ml
0.15
24
57
55
173
3.29
14.39
1.6
1.8
—
—
—
0
0
30
61
5.03
14.10
1.0
1.0
380.44
282.32
ng/l
0.64
25
38
66
238
2.88
13.69
1.8
1.2
5.80
6.17
u/ml
—
5
15
795
6648
1.68
13.41
4.6
3.4
53.64
47.00
u/l
0.97
758
6314
482
3581
1.61
13.12
4.8
3.7
33.46
60.71
ng/l
0.87
353
2440
29
61
4.85
13.12
1.0
1.0
38.05
36.70
ng/l
0.07
23
37
29
61
4.85
13.12
1.0
1.0
687.65
624.41
ng/l
0.29
23
39
30
65
4.72
13.11
1.2
1.6
—
—
—
0
0
17
6
28.73
12.98
1.1
1.0
—
—
—
0
0
136
699
2.08
12.96
1.9
1.7
—
—
—
0
0
69
266
2.70
12.64
1.7
1.6
—
—
—
0
0
74
296
2.61
12.61
1.8
1.2
17.57
2.49
u/ml
0.88
12
27
152
822
1.98
12.58
2.9
3.1
67.87
70.75
e9/l
0.39
104
609
382
2706
1.63
12.51
1.9
1.7
17.65
20.13
nmol/l
4.10
350
2313
166
929
1.92
12.43
2.4
2.5
37.29
37.92
u/l
0.02
149
770
60
219
2.84
12.19
1.3
1.5
161.94
155.74
au/ml
0.15
18
63
73
297
2.56
12.02
1.8
1.2
8.24
8.93
u/ml
0.05
19
44
59
219
2.79
11.63
1.5
1.7
—
—
—
0
0
41
124
3.39
11.44
1.3
1.5
280.31
279.52
mosm/kgh2o
0.05
32
88
65
256
2.63
11.43
3.0
3.8
3.23
2.37
ratio
0.25
47
147
64
251
2.64
11.35
1.2
1.4
319.22
235.48
u/ml
0.71
36
154
53
189
2.89
11.25
1.6
1.5
—
—
—
0
0
415
3059
1.57
11.21
3.0
2.6
56.70
61.83
u/l
1.07
392
2866
1026
9418
2.09
10.58
29.4
15.6
24.24
23.77
mg/l
0.19
933
7727
74
327
2.35
10.22
3.5
2.7
188.71
184.92
%
0.16
69
313
55
211
2.69
10.20
1.8
1.5
—
—
—
0
0
129
710
1.92
10.09
1.6
1.3
114.83
236.38
u/ml
1.95
120
659
67
286
2.43
9.99
3.0
4.0
80.19
40.77
mg/l
0.44
58
243
67
286
2.43
9.99
3.0
4.0
39.24
69.43
mg/l
0.76
57
243
131
731
1.90
9.82
4.3
4.3
81.18
84.77
ng/l
0.21
114
652
23
51
4.58
9.80
1.4
1.1
—
—
—
0
0
44
154
2.93
9.68
1.3
1.6
—
—
—
0
0
269
1845
1.60
9.65
3.2
2.9
2.45
2.44
mmol/l
0.33
237
1670
231
1528
1.65
9.60
3.1
2.6
2.27
2.32
g/l
0.68
219
1418
1023
9459
1.96
9.12
32.3
18.1
139.10
139.65
mmol/l
8.87
1018
9289
30
86
3.56
9.11
1.1
1.0
—
—
—
0
0
746
6390
1.50
9.11
3.4
3.2
—
—
—
0
0
214
1406
1.65
9.09
3.3
2.6
21.17
23.00
%
1.26
202
1321
335
2453
1.52
8.90
3.3
2.9
338.28
342.44
umol/l
0.27
296
2185
75
354
2.20
8.89
1.9
1.9
—
—
—
0
0
24
60
4.07
8.82
1.3
1.1
—
—
—
0
0
156
949
1.75
8.81
3.0
2.5
0.22
0.21
g/l
0.74
143
890
50
198
2.60
8.74
1.4
1.6
—
—
—
0
0
326
2386
1.52
8.63
2.8
2.4
—
—
—
0
0
551
4478
1.45
8.58
3.2
2.9
—
—
estimate
—
0
0
57
243
2.42
8.55
1.8
1.2
30.56
55.07
u/ml
—
7
22
39
137
2.91
8.55
1.7
1.6
—
—
—
0
0
239
1637
1.59
8.51
3.2
2.6
12.08
13.22
umol/l
1.68
226
1527
1021
9475
1.89
8.39
32.5
18.2
3.95
3.97
mmol/l
0.66
1013
9291
77
380
2.10
8.17
1.4
1.4
—
—
—
0
0
837
7414
1.51
8.10
5.1
4.3
14.81
14.72
pmol/l
0.44
797
6857
358
2714
1.47
7.84
3.2
3.4
1205.99
1265.43
ng/l
0.15
309
2311
27
80
3.43
7.83
1.2
1.7
—
—
—
0
0
27
80
3.43
7.83
1.2
1.7
—
—
—
0
0
27
80
3.43
7.83
1.2
1.7
—
—
—
0
0
37
133
2.84
7.80
1.8
1.6
—
—
—
0
0
955
8740
1.64
7.71
6.3
5.3
1.79
1.89
mu/l
1.85
904
8165
32
107
3.05
7.66
1.4
1.2
—
—
—
0
0
61
283
2.22
7.57
1.4
1.3
—
—
—
0
0
28
88
3.24
7.42
1.4
1.1
—
—
—
0
0
22
60
3.72
7.21
1.5
1.3
—
—
—
0
0
114
674
1.77
7.09
4.8
4.3
5.23
5.11
kpa
0.81
109
656
43
176
2.50
7.08
2.2
2.1
5.01
4.81
mmol/24h
0.16
35
157
28
91
3.13
7.04
1.4
1.1
—
—
—
0
0
28
91
3.13
7.04
1.4
1.1
—
—
—
0
0
29
97
3.04
6.96
1.4
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
60
287
2.15
6.93
3.4
3.2
0.32
0.36
iu/ml
0.24
31
159
101
581
1.81
6.88
4.6
4.3
1.78
1.65
mmol/l
0.14
80
433
27
88
3.12
6.77
1.4
1.1
—
—
—
0
0
21
58
3.67
6.77
1.3
2.0
29.38
29.11
umol/l
0.05
21
53
41
168
2.50
6.74
1.4
1.1
37198.14
69.20
iu/ml
—
7
34
568
4794
1.38
6.38
3.8
3.1
150.13
117.02
ug/l
1.16
529
4506
143
932
1.61
6.18
4.2
3.3
—
—
—
0
0
90
518
1.80
6.14
1.7
1.5
—
—
—
0
0
9
6
15.10
5.91
1.2
1.2
—
—
—
0
0
167
1141
1.55
5.89
3.1
3.2
7.79
8.06
umol/l
0.07
141
1008
963
8957
1.54
5.84
25.2
14.6
84.74
83.72
ml/min/173m2
0.65
907
8261
51
248
2.11
5.69
4.0
3.3
2.11
2.23
index
0.07
27
146
108
679
1.65
5.39
2.4
3.3
179.37
205.31
ng/l
0.21
100
619
24
88
2.77
4.96
2.7
4.8
45.17
37.33
u/ml
—
6
27
17
51
3.37
4.90
13.9
8.0
5916.38
45.13
u/ml
—
8
15
348
2809
1.35
4.85
6.2
3.9
0.00
0.01
estimate
1.34
126
1009
8
7
11.50
4.79
1.4
7.1
—
—
—
0
0
1041
9939
1.69
4.75
33.9
19.7
77.55
76.52
umol/l
0.41
1036
9844
112
736
1.58
4.69
2.3
2.4
4.28
7.91
ug/l
3.58
93
652
95
603
1.63
4.59
3.2
3.6
4.41
4.61
pmol/l
1.02
80
537
251
1942
1.38
4.56
1.6
1.7
30568130.08
36425075.30
pmol/l
0.07
229
1639
21
76
2.80
4.46
1.1
1.1
0.09
1.57
nmol/l
—
5
14
1033
9870
1.61
4.36
19.1
11.8
27.58
26.71
u/l
0.76
1014
9639
27
113
2.42
4.33
1.9
1.7
19.70
26.73
ng/l
0.99
27
113
15
45
3.37
4.33
1.1
1.8
—
—
—
0
0
15
45
3.37
4.33
1.1
1.8
—
—
—
0
0
15
45
3.37
4.33
1.1
1.8
—
—
—
0
0
15
45
3.37
4.33
1.1
1.8
—
—
—
0
0
10
16
6.30
4.30
2.2
1.3
—
—
—
0
0
460
3922
1.29
4.21
6.0
3.7
0.02
0.03
estimate
0.22
110
910
21
80
2.66
4.08
1.5
2.7
821.52
1138.74
mg
0.43
21
80
109
737
1.53
4.04
1.3
1.2
169.27
148.53
u/ml
0.17
38
296
108
729
1.53
4.04
1.4
1.5
—
—
—
0
0
17
58
2.96
4.02
1.4
1.4
15.76
23.76
umol/l
0.78
17
51
16
53
3.05
3.97
1.4
1.3
—
—
—
0
0
16
53
3.05
3.97
1.4
1.3
—
—
—
0
0
13
33
3.97
3.80
1.1
2.0
—
—
—
0
0
13
33
3.97
3.80
1.1
2.0
—
—
—
0
0
173
1296
1.40
3.78
1.8
1.9
1.56
1.47
%
0.98
147
1149
7
8
8.80
3.77
1.0
7.1
—
—
—
0
0
52
296
1.79
3.77
1.3
1.4
—
—
—
0
0
11
24
4.62
3.75
3.5
2.2
15.35
16.38
umol/l
0.11
11
24
13
34
3.86
3.70
1.1
2.0
—
—
—
0
0
15
50
3.03
3.69
1.6
2.0
—
—
—
0
0
15
50
3.03
3.69
1.6
2.0
—
—
—
0
0
33
163
2.06
3.63
1.2
1.1
—
—
—
0
0
13
35
3.75
3.60
3.4
3.4
28.57
34.35
umol/l
—
7
27
17
63
2.72
3.50
1.4
1.6
—
—
—
0
0
233
1851
1.33
3.50
1.4
1.3
20.77
28.35
iu/ml
1.14
71
554
19
76
2.53
3.39
1.4
1.6
—
—
—
0
0
357
3013
1.27
3.37
5.3
4.3
11.05
9.60
mg/mmol
0.26
242
1925
16
61
2.65
3.14
4.2
3.4
0.87
0.90
index
0.08
16
61
13
44
2.98
3.14
2.5
2.4
43.44
81.72
ug/l
1.38
13
44
22
98
2.27
3.14
3.1
2.5
23.70
21.41
mg/l
—
10
42
76
504
1.54
3.12
1.1
1.1
—
0.88
—
0
6
75
497
1.55
3.09
2.1
1.7
0.56
0.31
mg/l
1.36
29
233
278
2301
1.28
3.04
6.1
3.9
1.02
1.67
kg/l
0.50
199
1537
26
126
2.09
3.04
1.4
1.4
4522.49
360.96
pmol/l
0.47
21
111
9
21
4.31
3.00
1.1
1.4
—
—
—
0
0
5
5
10.04
2.98
1.2
1.0
—
—
—
0
0
20
88
2.30
2.95
1.1
1.1
103.85
107.70
pmol/l
0.14
20
88
30
156
1.95
2.92
1.2
1.3
—
—
—
0
0
101
725
1.43
2.84
5.6
3.8
1.21
1.23
mmol/l
1.86
90
629
13
47
2.79
2.82
1.0
1.1
—
—
—
0
0
378
3271
1.24
2.78
5.0
3.5
7.58
7.84
mmol/l
0.45
324
2823
290
2446
1.25
2.68
1.4
1.3
1.02
1.55
u/ml
0.84
57
686
12
43
2.81
2.65
1.3
2.3
2.48
1.97
umol/l
1.42
12
38
13
49
2.67
2.63
1.9
4.8
69.85
66.03
mg/l
0.12
13
36
20
93
2.17
2.62
1.1
1.3
—
79.50
—
0
6
19
87
2.20
2.58
2.6
2.9
—
—
—
0
0
5
7
7.17
2.55
1.0
1.0
—
—
—
0
0
14
57
2.47
2.45
1.4
1.6
—
—
—
0
0
5
8
6.27
2.37
10.0
15.8
0.22
0.29
umol/l
—
5
8
58
846
0.67
2.35
1.4
1.7
3.38
3.49
mmol/l
0.31
40
610
55
364
1.54
2.34
1.8
1.7
—
—
—
0
0
13
54
2.42
2.20
1.5
1.6
—
—
—
0
0
43
273
1.60
2.20
1.9
2.0
6.85
4.51
iu/l
0.61
15
109
63
436
1.47
2.19
2.1
2.4
4002.80
5077.80
u/l
0.16
20
193
8
24
3.35
2.18
2.5
3.6
10.34
10.18
kpa
—
8
24
8
24
3.35
2.18
2.5
3.6
4.46
4.85
kpa
—
8
24
45
290
1.57
2.17
1.2
1.2
—
—
—
0
0
11
42
2.63
2.14
2.9
2.3
—
—
—
0
0
45
291
1.57
2.14
1.2
1.2
—
—
—
0
0
9
31
2.92
2.07
2.8
2.9
0.61
0.60
mmol/l
—
9
31
22
117
1.90
2.07
1.0
1.2
0.19
0.18
nmol/l
0.23
17
87
6
15
4.02
2.04
1.2
1.0
—
—
—
0
0
19
98
1.96
1.96
3.6
3.6
—
—
—
0
0
19
98
1.96
1.96
1.9
2.2
16.77
20.97
nmol/l
1.96
19
91
5
11
4.56
1.94
1.2
1.7
—
—
—
0
0
5
11
4.56
1.94
3.2
2.2
—
—
—
0
0
55
385
1.45
1.84
1.3
1.3
245.28
256.33
miu/ml
0.06
21
184
13
59
2.22
1.84
1.7
1.7
—
—
—
0
0
327
2889
1.19
1.83
5.3
3.3
0.00
0.04
estimate
0.77
111
875
97
751
1.32
1.79
2.9
2.6
76.98
68.27
ml/min/173m2
0.26
41
318
5
13
3.86
1.71
3.2
2.1
—
—
—
0
0
89
1139
0.76
1.69
1.7
1.9
3.58
3.53
ratio
0.11
68
890
109
868
1.28
1.65
2.3
2.4
12.88
13.06
nmol/l
0.07
99
800
10
42
2.39
1.62
1.1
1.3
97.00
94.89
nmol/l
—
5
29
36
240
1.52
1.56
2.5
2.0
124.91
130.17
g/l
0.57
23
192
5
15
3.34
1.52
1.2
1.0
179.20
64.00
titre
—
5
15
16
86
1.87
1.51
1.2
1.2
1.07
4.76
u/ml
—
9
45
15
79
1.91
1.50
1.9
1.8
—
—
—
0
0
13
242
0.53
1.48
1.5
1.6
—
—
—
0
0
42
294
1.45
1.46
1.8
1.4
277.67
291.22
ug/g
0.12
26
174
197
1698
1.19
1.45
1.3
1.3
9.81
10.72
u/ml
0.09
69
666
12
59
2.05
1.44
1.0
1.2
6.14
12.02
u/l
—
7
54
17
95
1.80
1.43
1.9
1.7
—
—
—
0
0
9
39
2.32
1.43
1.2
1.4
—
—
—
0
0
9
39
2.32
1.43
1.2
1.4
—
—
—
0
0
28
181
1.56
1.41
1.2
1.3
140.92
35.67
u/l
0.63
21
159
121
998
1.24
1.39
9.4
6.8
—
—
—
0
0
6
23
2.62
1.37
1.2
1.2
—
—
—
0
0
1048
10285
1.30
1.35
41.1
23.6
7.12
6.76
e9/l
4.95
1033
10079
1047
10277
1.30
1.32
41.2
23.6
256.56
251.28
e9/l
1.67
1036
10097
27
403
0.66
1.32
1.2
1.9
4.01
4.16
mg/l
0.04
19
295
1047
10278
1.29
1.31
41.0
23.5
91.09
90.74
fl
1.49
1040
10190
9
43
2.10
1.30
1.2
1.1
416.22
469.32
u/l
—
9
38
899
8700
1.17
1.30
7.3
6.1
39.92
39.00
mmol/mol
1.73
851
8216
1047
10281
1.29
1.28
42.4
24.1
39.63
40.51
%
8.52
1039
10186
1047
10281
1.29
1.28
41.1
23.5
4.39
4.52
e12/l
13.20
1030
10080
159
1361
1.20
1.28
2.6
2.7
191.19
121.02
ug/g
0.80
132
1101
8
36
2.23
1.24
1.3
1.2
—
—
—
0
0
1047
10286
1.28
1.23
41.5
23.7
131.97
135.83
g/l
14.14
1039
10194
163
1404
1.19
1.23
2.2
2.2
—
—
—
0
0
151
1292
1.20
1.22
2.1
2.1
—
—
—
0
0
35
251
1.41
1.11
1.5
1.4
—
—
—
0
0
5
21
2.39
1.09
1.6
1.1
—
—
—
0
0
38
279
1.37
1.07
1.7
1.9
173.12
216.14
pmol/l
1.54
33
265
19
121
1.58
1.06
1.3
1.5
—
—
—
0
0
7
33
2.13
1.05
2.4
4.6
—
—
—
0
0
9
46
1.96
1.03
4.3
3.3
1.00
1.48
%
—
9
46
18
114
1.59
1.03
1.3
1.5
—
—
—
0
0
18
114
1.59
1.03
1.3
1.5
—
—
—
0
0
7
34
2.07
1.03
1.4
1.1
119.57
104.90
%
—
7
29
19
123
1.55
1.00
1.3
1.5
—
—
—
0
0
19
123
1.55
1.00
1.3
1.5
—
—
—
0
0
18
115
1.57
1.00
1.3
1.5
—
—
—
0
0
42
545
0.76
0.96
1.6
1.6
796.06
967.13
mu/l
0.95
32
459
21
141
1.50
0.95
1.4
1.5
—
—
—
0
0
19
125
1.53
0.94
1.1
1.3
—
—
—
0
0
94
793
1.20
0.93
2.2
2.1
—
—
—
0
0
80
666
1.22
0.90
2.1
2.0
—
—
—
0
0
25
177
1.42
0.89
1.6
1.7
—
—
—
0
0
224
2030
1.13
0.88
1.8
1.6
—
—
—
0
0
8
46
1.74
0.82
1.6
1.1
125.71
209.15
iu/ml
—
8
46
8
47
1.71
0.80
2.8
1.7
155.38
93.90
ng/l
—
8
47
124
1088
1.16
0.79
4.3
4.6
31.29
31.72
%
0.14
90
732
898
9173
0.89
0.78
5.1
4.8
1.42
1.45
mmol/l
1.15
835
8565
43
340
1.28
0.78
1.6
1.4
10.36
9.31
u/l
0.19
34
274
300
2785
1.11
0.77
4.2
5.3
2.35
2.48
ug/l
0.11
276
2516
12
185
0.64
0.75
1.8
1.6
53.51
53.98
ug/l
0.02
12
185
105
918
1.16
0.72
3.7
4.4
6.87
24.35
ug/l
1.15
84
756
13
85
1.54
0.69
1.5
2.1
—
—
—
0
0
63
532
1.20
0.66
1.2
1.4
—
—
—
0
0
13
86
1.52
0.66
1.3
1.4
15942.87
38765.84
e6/l
—
8
43
15
213
0.70
0.65
1.9
1.8
—
—
—
0
0
28
217
1.30
0.62
2.3
2.5
107.44
115.58
ug/min
0.06
17
134
65
555
1.18
0.61
1.1
1.0
—
—
—
0
0
28
219
1.29
0.59
1.1
1.2
—
—
—
0
0
906
9215
0.91
0.58
5.2
4.9
4.54
4.64
mmol/l
2.22
846
8658
6
35
1.72
0.57
2.8
1.7
—
—
—
0
0
29
364
0.79
0.57
1.7
1.5
—
—
—
0
0
30
238
1.27
0.57
1.9
1.6
10845.83
12996.69
e6/l
0.17
23
173
22
167
1.32
0.57
4.4
3.3
0.86
0.86
nmol/l
0.01
17
136
6
38
1.58
0.54
2.3
1.4
—
—
—
0
0
9
63
1.43
0.52
1.6
1.6
—
—
—
0
0
16
120
1.34
0.46
2.1
2.6
1.20
1.19
mmol/l
0.12
16
120
37
312
1.19
0.43
1.5
1.5
—
—
—
0
0
14
104
1.35
0.43
1.1
1.3
—
—
titre
—
0
0
16
122
1.32
0.42
2.1
2.6
4.20
4.08
mmol/l
0.60
16
122
16
122
1.32
0.42
2.1
2.6
104.31
105.24
mmol/l
0.17
16
122
0
15
0.00
0.41
0.0
1.0
—
0.75
—
0
10
177
1657
1.08
0.41
2.9
3.1
0.74
0.76
ug/l
0.06
122
1003
0
16
0.00
0.41
0.0
1.1
—
28.63
—
0
10
59
524
1.13
0.38
1.4
1.4
28.41
24.46
iu/l
0.36
47
438
5
37
1.35
0.37
1.2
1.2
—
—
—
0
0
33
281
1.18
0.36
1.1
1.1
1.68
6.40
eliau/ml
—
5
36
923
9326
0.94
0.31
5.9
5.5
2.61
2.73
mmol/l
4.10
857
8730
27
315
0.85
0.31
1.5
1.4
—
—
—
0
0
33
377
0.87
0.29
1.2
1.1
0.60
0.66
ratio
—
6
42
381
3922
0.96
0.28
2.0
1.9
1.42
1.37
mmol/l
0.62
332
3372
10
77
1.30
0.26
1.4
1.2
—
—
—
0
0
10
77
1.30
0.26
1.4
1.2
—
—
—
0
0
37
414
0.89
0.25
1.3
1.1
0.95
0.91
g/l
0.48
37
414
899
8907
1.05
0.23
5.4
4.9
6.04
5.91
mmol/l
1.50
834
8235
36
401
0.89
0.23
1.3
1.1
1.51
1.54
g/l
0.20
36
401
12
146
0.82
0.22
1.3
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
2.5
—
0.55
—
0
11
0
11
0.00
0.21
0.0
1.0
—
9.10
—
0
5
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
3.12
—
0
5
0
13
0.00
0.21
0.0
1.0
—
0.05
—
0
6
21
240
0.87
0.20
1.1
1.1
1.70
3.16
u/ml
0.49
15
133
0
14
0.00
0.20
0.0
1.0
—
0.00
—
0
7
6
53
1.13
0.18
1.2
1.2
6.33
8.74
mm/h
—
6
53
14
119
1.18
0.17
1.1
1.1
—
—
—
0
0
28
310
0.90
0.17
1.4
1.5
1.06
0.95
ratio
0.83
14
197
28
310
0.90
0.17
1.4
1.5
1.25
1.17
ratio
0.15
14
197
28
310
0.90
0.17
1.4
1.5
0.87
1.19
ratio
2.02
16
197
18
159
1.13
0.15
1.1
1.1
4.07
1.94
eliau/ml
—
6
70
868
8739
0.97
0.15
4.5
4.2
1.37
1.29
mmol/l
2.11
804
8096
158
1533
1.04
0.14
1.6
1.5
—
—
—
0
0
28
305
0.92
0.14
1.4
1.4
—
—
—
0
0
30
325
0.92
0.13
1.5
1.6
48.74
60.60
ug/l
0.84
22
278
14
123
1.14
0.12
2.6
2.7
33.29
32.97
pg
0.12
14
123
17
154
1.11
0.10
1.8
2.8
6.83
7.21
umol/l
—
9
119
226
2220
1.02
0.09
3.7
4.3
21.17
21.22
%
0.02
96
998
39
373
1.05
0.07
1.8
1.8
—
—
—
0
0
13
132
0.98
0.00
1.0
1.1
—
—
—
0
0
15
147
1.02
0.00
1.4
1.3
—
—
—
0
0
38
375
1.01
0.00
1.8
1.7
10.63
8.33
u/ml
—
7
87
0
9
0.00
0.00
0.0
1.0
—
0.10
—
0
9
7
77
0.91
0.00
1.1
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
68
0.88
-0.00
1.0
1.5
84.67
79.66
umol/l
—
6
68
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
1.36
—
0
7
6
61
0.98
-0.00
1.2
1.5
—
243.33
—
0
6
0
7
0.00
-0.00
0.0
1.6
—
6.17
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_ENCEPHOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_ENCEPHOTH | 2.45 [2.02, 2.98] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.037 |
During the follow-up period (1.1.1998 — 31.12.2019), 661 out of 2876 females with G6_ENCEPHOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_ENCEPHOTH | 2.573 [2.12, 3.12] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.009 |
During the follow-up period (1.1.1998 — 31.12.2019), 676 out of 2598 males with G6_ENCEPHOTH died.
Mortality risk
Mortality risk for people of age
years, who have G6_ENCEPHOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.27% | 0.56% |
| 5 | 1.504% | 3.404% |
| 10 | 3.471% | 7.97% |
| 15 | 6.499% | 14.497% |
| 20 | 10.676% | 23.104% |
Relationships between endpoints
↥Index endpoint: G6_ENCEPHOTH – Other encephalitis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data